Investing Profile

Ohad Hammer

InvestorVCScout
Partner at Pontifax Venture Capital
hammerstockblog.comIsrael
Photo of Ohad Hammer, Partner at Pontifax Venture Capital
Your Intro Paths to Ohad Hammer

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Ohad Hammer on

cb
Current Investing Position
Pontifax Venture Capital Partner
Investment Range
$10.0M - $50.0M
Sweet Spot
$25.0M
Investments On Record
11

Ohad Hammer is on these Sector & Stage Rankings

Ohad Hammer's Investments On Record (8)

CompanyStageDateRound SizeTotal Raised
AgomAb Therapeutics
Series COct 2023$100M
Series BMar 2021$74M
Series AApr 2019$24M
$200M
Co-investors: Colleen Cuffaro (Canaan Partners), Felice Verduyn - van Weegen (EQT Life Sciences), Iyona Rajkomar (Pontifax Venture Capital)
ADCendo
Series AApr 2023$34M
$96M
Co-investors: Reza Halse (RA Capital), Marten Steen (HealthCap), Joël Jean-Mairet (Ysios Capital)
Anaveon
Series BDec 2021$120M
$160M
Co-investors: Florian Müllershausen (Novartis Venture Fund), Jasper Bos (Forbion), Denis Patrick (Pfizer Venture Investments)
Emergence Therapeutics
Series ADec 2021$98M
$98M
Co-investors: Anke Cassing (High-Tech Gründerfonds), Thierry Laugel (Kurma Partners)
Step Pharma
Series BMar 2021$41M
Series ANov 2017$17M
$61M
Co-investors: Vanessa Malier (Kurma Partners)
Amolyt Pharma
Series AJul 2019$74M
$290M
Co-investors: Felice Verduyn - van Weegen (EQT Life Sciences), Raphael Wisniewski (Andera Partners), Iyona Rajkomar (Pontifax Venture Capital), Cedric Moreau (Soffinova Partners), Thierry Laugel (Kurma Partners)
Precirix
Series ANov 2018$42M
$130M
Co-investors: Jasper Bos (Forbion), Simone Botti (INKEF Capital), Marten Steen (HealthCap)
Coave Therapeutics
Series BNov 2017$22M
$22M
Co-investors: Thierry Laugel (Kurma Partners)